CIK 0001274737
- Non-accelerated filer
- Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 760-560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 40,401 shares at $1.92 ($77,570)
- 4 Open-market sale CFO and Corporate Secretary sold 12,784 shares at an average $1.91 ($24,407)
- 4 Grant or award President and CEO acquired 9,804 shares (grant or award)
- 4 Grant or award CFO and Corporate Secretary acquired 75,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 175,000 shares (grant or award)
- 4 Open-market sale CFO and Corporate Secretary sold 6,738 shares at $1.95 ($13,133)
- 4 Open-market sale President and CEO sold 33,819 shares at $1.75 ($59,018)
- 4 Grant or award President and CEO acquired 9,803 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 167 shares at $3.11 ($519)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 9 · 168 filings